Vivesto AB (VIVE.ST)
VIVE.ST Stock Price Chart
Explore Vivesto AB interactive price chart. Choose custom timeframes to analyze VIVE.ST price movements and trends.
VIVE.ST Company Profile
Discover essential business fundamentals and corporate details for Vivesto AB (VIVE.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
24 Jun 2010
Employees
4.00
Website
https://www.vivesto.comCEO
Erik Kinnman Assoc. Prof.,
Description
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
VIVE.ST Financial Timeline
Browse a chronological timeline of Vivesto AB corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 18 Feb 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 12 Aug 2025
Earnings released on 8 May 2025
Earnings released on 20 Feb 2025
Earnings released on 14 Nov 2024
Earnings released on 22 Aug 2024
Earnings released on 23 May 2024
Earnings released on 22 Feb 2024
Earnings released on 16 Nov 2023
Earnings released on 24 Aug 2023
EPS came in at -kr 0.05 .
Earnings released on 25 May 2023
EPS came in at -kr 0.04 .
Earnings released on 23 Feb 2023
EPS came in at -kr 0.44 .
Earnings released on 17 Nov 2022
EPS came in at -kr 0.14 , while revenue for the quarter reached kr 1.02M .
Earnings released on 25 Aug 2022
EPS came in at -kr 0.07 .
Earnings released on 25 May 2022
EPS came in at -kr 0.06 surpassing the estimated -kr 0.09 by +33.33%.
Earnings released on 24 Feb 2022
EPS came in at -kr 0.01 , while revenue for the quarter reached kr 9.64M , beating expectations by +4.72K%.
Earnings released on 18 Nov 2021
EPS came in at -kr 0.07 surpassing the estimated -kr 0.09 by +22.22%, while revenue for the quarter reached kr 11.92M , beating expectations by +5.86K%.
Earnings released on 19 Aug 2021
EPS came in at -kr 0.12 falling short of the estimated -kr 0.09 by -33.33%, while revenue for the quarter reached kr 4.60M , beating expectations by +2.20K%.
Earnings released on 27 May 2021
EPS came in at -kr 0.09 , while revenue for the quarter reached kr 37.00K , missing expectations by -97.36%.
Earnings released on 19 Feb 2021
EPS came in at -kr 0.49 , while revenue for the quarter reached -kr 200.16M .
Earnings released on 9 Dec 2020
EPS came in at -kr 0.12 falling short of the estimated -kr 0.10 by -20.00%, while revenue for the quarter reached kr 154.00K .
Earnings released on 9 Sept 2020
EPS came in at -kr 0.12 matching the estimated -kr 0.12, while revenue for the quarter reached kr 208.00K .
VIVE.ST Stock Performance
Access detailed VIVE.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.